Article

Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and…

medRxiv · 2019 · Liau, Y.; Maggo, S.; Miller, A. L.; Pearson, J. F.; Kennedy, M. A.; Cree, S. L.

Key facts

Title Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications
First author Liau, Y.; Maggo, S.; Miller, A. L.; Pearson, J. F.; Kennedy, M. A.; Cree, S. L.
Journal medRxiv
Published Jun 8, 2019
DOI 10.1101/576280
Devices mentioned K110701, K141410, K152556, K192920
Product codes mentioned OYJ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature